Yoon Jeon Selected Research

Phenformin (Fenformin)

5/2021	Reply to Krupenko et al. Comment on "Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382".
1/2021	Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse.
5/2020	The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoon Jeon Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 06/2012
3	Carcinogenesis 07/2021 - 05/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 12/2016
2	Lung Neoplasms (Lung Cancer) 05/2021 - 05/2020
2	Inflammation (Inflammations) 10/2019 - 12/2010
1	Colorectal Neoplasms (Colorectal Cancer) 07/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021
1	Adenocarcinoma 01/2021
1	Adenocarcinoma of Lung 05/2020
1	Sepsis (Septicemia) 01/2020
1	Hemorrhage 01/2020
1	Lung Injury 01/2020
1	Acute Lung Injury 01/2020
1	Colitis 10/2019
1	Infertility (Sterility) 01/2019
1	Acute Radiation Syndrome 10/2018
1	Intestinal Failure 10/2018
1	Melanoma (Melanoma, Malignant) 10/2018
1	Adenoma (Adenomas) 05/2017
1	Colonic Neoplasms (Colon Cancer) 05/2017
1	Atrial Fibrillation 07/2014
1	Type 2 Diabetes Mellitus (MODY) 06/2012
1	Chronic Disease (Chronic Diseases) 06/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2012
1	Alzheimer Disease (Alzheimer's Disease) 06/2012
1	Genomic Instability 06/2012
1	Ureteral Obstruction 12/2010
1	Hyperlipidemias (Hyperlipidemia) 01/2006
1	Fatty Liver 01/2006

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2019
3	Phenformin (Fenformin)IBA 05/2021 - 05/2020
2	Niclosamide FDA Link 07/2021 - 05/2017
2	Therapeutic UsesIBA 05/2021 - 01/2021
2	EnzymesIBA 01/2021 - 05/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Protein Kinase C-thetaIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 07/2021
1	GossypolIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2021
1	Aldehyde DehydrogenaseIBA 01/2021
1	AldehydesIBA 01/2021
1	CarbonIBA 05/2020
1	10-formyltetrahydropteroylglutamic acidIBA 05/2020
1	antineoplaston A10 (A 10)IBA 05/2020
1	5,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA 05/2020
1	NAD (NADH)IBA 05/2020
1	LipopolysaccharidesIBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	YS-01IBA 01/2020
1	Factor XIa (Coagulation Factor XIa)IBA 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2019
1	Transcription Factors (Transcription Factor)IBA 10/2019
1	Dextran SulfateIBA 10/2019
1	Tamoxifen FDA LinkGeneric 10/2018
1	RELTIBA 10/2018
1	Cadherins (E-Cadherin)IBA 05/2017
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2017
1	Member 1 Group D Nuclear Receptor Subfamily 1IBA 12/2016
1	DNA (Deoxyribonucleic Acid)IBA 12/2016
1	Potassium Channels (Potassium Channel)IBA 07/2014
1	hexosaminidase CIBA 06/2012
1	O-GlcNAc transferaseIBA 06/2012
1	Protein Glutamine gamma Glutamyltransferase 2IBA 12/2010
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2006
1	AdiponectinIBA 01/2006
1	Insulin (Novolin)FDA Link 01/2006
1	CorticosteroneIBA 01/2006
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2006
1	muraglitazarIBA 01/2006

Therapy/Procedure

2	Oral Administration 07/2021 - 05/2017
1	Therapeutics 01/2020